Stéphan Ellmerich

1.6k total citations
22 papers, 1.1k citations indexed

About

Stéphan Ellmerich is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Stéphan Ellmerich has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Surgery. Recurrent topics in Stéphan Ellmerich's work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Stéphan Ellmerich is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Stéphan Ellmerich collaborates with scholars based in United Kingdom, Italy and United States. Stéphan Ellmerich's co-authors include M Schöller, F. Raul, Francine Gossé, B Duranton, M. Galluser, J.P. Klein, Raya Al‐Shawi, Mark B. Pepys, J. Paul Simons and Vittorio Bellotti and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Stéphan Ellmerich

22 papers receiving 1.1k citations

Peers

Stéphan Ellmerich
Bruce Motyka Canada
Anthony Secreto United States
Domenico Angelucci Italy
M. Talbot Canada
Jonathan G. Lieber United States
Piotr Wierzbicki Poland
Joan Ní Gabhann Ireland
Yusuke Shono Japan
Shi‐Chuen Miaw Taiwan
Christine T. N. Pham United States
Bruce Motyka Canada
Stéphan Ellmerich
Citations per year, relative to Stéphan Ellmerich Stéphan Ellmerich (= 1×) peers Bruce Motyka

Countries citing papers authored by Stéphan Ellmerich

Since Specialization
Citations

This map shows the geographic impact of Stéphan Ellmerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphan Ellmerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphan Ellmerich more than expected).

Fields of papers citing papers by Stéphan Ellmerich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphan Ellmerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphan Ellmerich. The network helps show where Stéphan Ellmerich may publish in the future.

Co-authorship network of co-authors of Stéphan Ellmerich

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphan Ellmerich. A scholar is included among the top collaborators of Stéphan Ellmerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphan Ellmerich. Stéphan Ellmerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Amand F., Chris Finan, Sandesh Chopade, et al.. (2024). Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders. Open Biology. 14(7). 230419–230419. 4 indexed citations
2.
Ellmerich, Stéphan, Janet A. Gilbertson, Diana Canetti, et al.. (2021). Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis. Nature Communications. 12(1). 7112–7112. 18 indexed citations
3.
Izco, María, Javier Blesa, Martin Schleef, et al.. (2019). Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology. Molecular Therapy. 27(12). 2111–2122. 173 indexed citations
4.
Mazza, Giuseppe, J. Paul Simons, Raya Al‐Shawi, et al.. (2015). Amyloid persistence in decellularized liver: biochemical and histopathological characterization. Amyloid. 23(1). 1–7. 17 indexed citations
5.
Disterer, Petra, Raya Al‐Shawi, Stéphan Ellmerich, et al.. (2013). Exon Skipping of Hepatic APOB Pre-mRNA With Splice-switching Oligonucleotides Reduces LDL Cholesterol In Vivo. Molecular Therapy. 21(3). 602–609. 26 indexed citations
6.
Campbell‐Washburn, Adrienne, Anthony N. Price, Stéphan Ellmerich, et al.. (2013). Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction. Amyloid. 20(2). 93–98. 6 indexed citations
7.
Simons, J. Paul, Raya Al‐Shawi, Stéphan Ellmerich, et al.. (2013). Pathogenetic mechanisms of amyloid A amyloidosis. Proceedings of the National Academy of Sciences. 110(40). 16115–16120. 75 indexed citations
8.
Pepys, Mark B., J. Ruth Gallimore, Joanne Lloyd, et al.. (2012). Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use. Journal of Immunological Methods. 384(1-2). 92–102. 29 indexed citations
9.
Ross, Jacob A., Ermanno Gherardi, Arthur J. Rowe, et al.. (2011). Protein Engineered Variants of Hepatocyte Growth Factor/Scatter Factor Promote Proliferation of Primary Human Hepatocytes and in Rodent Liver. Gastroenterology. 142(4). 897–906. 23 indexed citations
10.
Price, Anthony N., Stéphan Ellmerich, Raya Al‐Shawi, et al.. (2011). Equilibrium contrast CMR for the detection of amyloidosis in mice. Journal of Cardiovascular Magnetic Resonance. 13(S1). 5 indexed citations
11.
Alicot, Elisabeth M., Minghe Ma, Andrew Getahun, et al.. (2011). Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proceedings of the National Academy of Sciences. 108(43). E934–42. 27 indexed citations
12.
Bodin, Karl, Stéphan Ellmerich, Melvyn Kahan, et al.. (2010). Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature. 468(7320). 93–97. 245 indexed citations
13.
Hopkins, Philip, Alison C. Pridmore, Stéphan Ellmerich, et al.. (2008). Increased surface toll-like receptor 2 expression in superantigen shock. Critical Care Medicine. 36(4). 1267–1276. 16 indexed citations
14.
Faulkner, Lee, Daniel M. Altmann, Stéphan Ellmerich, et al.. (2007). Sexual Dimorphism in Superantigen Shock Involves Elevated TNF-α and TNF-α–induced Hepatic Apoptosis. American Journal of Respiratory and Critical Care Medicine. 176(5). 473–482. 26 indexed citations
15.
Ellmerich, Stéphan, Marcin P. Mycko, Katalin Takács, et al.. (2005). High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model. The Journal of Immunology. 174(4). 1938–1946. 57 indexed citations
16.
Ellmerich, Stéphan, Katalin Takács, Marcin P. Mycko, et al.. (2004). Disease‐related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. European Journal of Immunology. 34(7). 1839–1848. 41 indexed citations
17.
Illés, Zsolt, Joel N. H. Stern, Jayagopala Reddy, et al.. (2004). Modified amino acid copolymers suppress myelin basic protein 85–99-induced encephalomyelitis in humanized mice through different effects on T cells. Proceedings of the National Academy of Sciences. 101(32). 11749–11754. 33 indexed citations
18.
Taylor, Philip R., Hans J. Stauss, Ragnar Lindstedt, et al.. (2000). Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. European Journal of Immunology. 30(10). 2871–2880. 41 indexed citations
19.
Ellmerich, Stéphan, Nabil Djouder, M Schöller, & Jean‐Paul Klein. (2000). PRODUCTION OF CYTOKINES BY MONOCYTES, EPITHELIAL AND ENDOTHELIAL CELLS ACTIVATED BY STREPTOCOCCUS BOVIS. Cytokine. 12(1). 26–31. 52 indexed citations
20.
Ellmerich, Stéphan, M Schöller, B Duranton, et al.. (2000). Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis. 21(4). 753–756. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce Motyka Breakdown of academic impact, for papers by Anthony Secreto Breakdown of academic impact, for papers by Domenico Angelucci Breakdown of academic impact, for papers by M. Talbot Breakdown of academic impact, for papers by Jonathan G. Lieber Breakdown of academic impact, for papers by Piotr Wierzbicki Breakdown of academic impact, for papers by Joan Ní Gabhann Breakdown of academic impact, for papers by Yusuke Shono Breakdown of academic impact, for papers by Shi‐Chuen Miaw Breakdown of academic impact, for papers by Christine T. N. Pham
Rankless by CCL
2026